Ken Yoshikawa et al <br/><br/>
Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance Study 

<br/><br/><label>Subjects--Topical Terms: </label><br/>Computer science, information & general works